Product Information
XIIDRA 5% EYE DROPS is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $11.8311 per EA under NDC 00078091112. Its NADAC has been published 302 times since Nov 11, 2020.
FDA first approved this application on Jul 11, 2016.
Strength
50 mg/mL
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078091112
Classification
Brand
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
LIFITEGRASTApproval Type
New Drug (NDA)
FDA Application
NDA208073FDA Approved
7/11/2016
On Market Since
7/11/2016
Pharmacological Classes
Price Statistics
The NADAC for XIIDRA 5% EYE DROPS has been published 302 times since Nov 11, 2020, and over the history we have for it it has risen 33.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.8311 per EA |
|---|---|
| All-time high | $11.8386 (May 13, 2026) |
| All-time low | $8.8473 (Dec 23, 2020) |
| 52-week high | $11.8386 |
| 52-week low | $11.4891 |
| Median price | $10.9471 |
| Average price | $10.7319 |
| Largest weekly change | +8.0% (Jan 11, 2023) |
| Weeks tracked | 302 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of XIIDRA 5% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for XIIDRA 5% EYE DROPS, manufactured by Novartis Pharmaceuticals Corporation, is $11.8311 per EA (NDC 00078091112), effective Aug 19, 2026.
How has the price of XIIDRA 5% EYE DROPS changed over time?
Over the history we have for it, the NADAC for XIIDRA 5% EYE DROPS has risen 33.5%. It has been tracked across 302 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for XIIDRA 5% EYE DROPS?
Since Nov 11, 2020, the NADAC for XIIDRA 5% EYE DROPS has ranged from a low of $8.8473 (Dec 23, 2020) to a high of $11.8386 (May 13, 2026), with a median of $10.9471 per EA.
Are there cheaper alternatives to XIIDRA 5% EYE DROPS?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as XIIDRA 5% EYE DROPS in a comparable dosage form, but none are currently priced below it.
Who manufactures XIIDRA 5% EYE DROPS?
XIIDRA 5% EYE DROPS (NDC 00078091112) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.